Loukas Settas

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed

L.B.A. van de Putte, Michel Malaise, J Sany et al. · Annals of the Rheumatic Diseases · 2004 · 620 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival

Irini Flouri, Theodora E. Markatseli, Paraskevi V. Voulgari et al. · Seminars in Arthritis and Rheumatism · 2013 · 95 citations

Medicine, Pharmacology, Pharmacotherapy +16

Impaired Fibrinolysis as an Essential Contribution to Thrombosis in Patients with Lupus Anticoagulant

Dimitrios Α. Tsakiris, G A Marbet, P.E. Makris et al. · Thrombosis and Haemostasis · 1989 · 71 citations

Medicine, Hematology, Autoimmunity +16

Clinical expression and morbidity of systemic lupus erythematosus during a post-diagnostic 5-year follow-up: a male:female comparison

S Stefanidou, Alexis Benos, Vasiliki Galanopoulou et al. · Lupus · 2011 · 70 citations

Medicine, Pathology, Renal Pathology +11

Comparative Analysis and Predictors of 10-year Tumor Necrosis Factor Inhibitors Drug Survival in Patients with Spondyloarthritis: First-year Response Predicts Longterm Drug Persistence

Irini Flouri, Theodora E. Markatseli, Kyriaki Boki et al. · The Journal of Rheumatology · 2018 · 58 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14